Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Curr Dev Nutr ; 8(5): 102155, 2024 May.
Article in English | MEDLINE | ID: mdl-38689594

ABSTRACT

Background: Consumers of overnight home parenteral nutrition (HPN) often experience sleep disruption; however, existing healthy sleep recommendations are widely inapplicable to consumers. Objectives: The aim of this mixed-methods, community-based participatory research study was to develop tailored recommendations on healthy sleep practices for HPN consumers. Methods: The multipart study involved the following: 1) an initial draft of sleep recommendations based on the evaluation of existing general sleep hygiene guidelines by an expert panel of clinicians and consumers with lived experience; 2) semi-structured focus groups with consumers and clinicians; 3) pre- and post-knowledge tests completed by consumers, and 4) final approval of the recommendations by the expert panel. Results: The literature synthesis resulted in 51 recommendations evaluated for relevance for HPN consumers. Focus groups with 20 HPN consumers and clinicians contributed additional recommendations based on lived experience. Ultimately, the final resource included recommendations spanning 4 sections: getting ready for bed, preparing the bedroom for sleep, daytime behaviors, and overall strategies for better sleep. Of the 36 recommendations, 58% were derived from existing general sleep hygiene guidelines, and the remaining 42% addressed sleep challenges experienced uniquely by consumers, including nocturnal polyuria, noise/light from medical equipment, and infusion schedules. Knowledge tests completed by 10 additional consumers indicated a modest increase in sleep health knowledge. Conclusions: The curated healthy sleep resource tailored for HPN consumers was facilitated by a multidisciplinary expert panel, a strategic collaboration with members of the HPN community and their clinicians, and in partnership with patient advocacy and support organizations. The wide distribution of these resources may improve the overall well-being of HPN consumers.

2.
Cell Host Microbe ; 31(5): 751-765.e11, 2023 05 10.
Article in English | MEDLINE | ID: mdl-37098341

ABSTRACT

Treating and preventing infections by antimicrobial-resistant bacterial pathogens is a worldwide problem. Pathogens such as Staphylococcus aureus produce an array of virulence determinants, making it difficult to identify single targets for the development of vaccines or monoclonal therapies. We described a human-derived anti-S. aureus monoclonal antibody (mAb)-centyrin fusion protein ("mAbtyrin") that simultaneously targets multiple bacterial adhesins, resists proteolysis by bacterial protease GluV8, avoids Fc engagement by S. aureus IgG-binding proteins SpA and Sbi, and neutralizes pore-forming leukocidins via fusion with anti-toxin centyrins, while maintaining Fc- and complement-mediated functions. Compared with the parental mAb, mAbtyrin protected human phagocytes and boosted phagocyte-mediated killing. The mAbtyrin also reduced pathology, reduced bacterial burden, and protected from different types of infections in preclinical animal models. Finally, mAbtyrin synergized with vancomycin, enhancing pathogen clearance in an animal model of bacteremia. Altogether, these data establish the potential of multivalent mAbs for treating and preventing S. aureus diseases.


Subject(s)
Methicillin-Resistant Staphylococcus aureus , Staphylococcal Infections , Animals , Humans , Staphylococcus aureus , Staphylococcal Infections/drug therapy , Staphylococcal Infections/prevention & control , Staphylococcal Infections/microbiology , Antibodies, Monoclonal/therapeutic use , Phagocytes/metabolism , Leukocidins/metabolism , Leukocidins/therapeutic use
3.
Eur Addict Res ; 12(4): 182-6, 2006.
Article in English | MEDLINE | ID: mdl-16968993

ABSTRACT

BACKGROUND: Regional variations in rates of drug use have been described previously in relation to adolescents. However, reasons for these differences are not clear. Previous publications pointed to higher rates of drug use by Glasgow children compared to children living in Newcastle upon Tyne. This paper explores the hypothesis that a higher rate of drug use in Glasgow is due to higher availability there. METHOD: School surveys were conducted in Glasgow and Newcastle upon Tyne on a total of 2,318 children aged 10-12. These concerned aspects of behaviour, lifestyle, family life and drug use. FINDINGS: The data indicate that the higher rate of drug use by Glasgow children was attributable to greater opportunities for children to gather at leisure centres and other venues and activities facilitating exposure to more drug-experienced young people.


Subject(s)
Students/statistics & numerical data , Substance-Related Disorders/epidemiology , Urban Population/statistics & numerical data , Child , Female , Humans , Incidence , Male , Prevalence , Schools , Scotland/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...